MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹501 Cr | ₹402 Cr | ₹321 Cr | ₹456 Cr | ₹404 Cr |
What is the latest Total Current Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹501 Cr |
| Mar2024 | ₹402 Cr |
| Mar2023 | ₹321 Cr |
| Mar2022 | ₹456 Cr |
| Mar2021 | ₹404 Cr |
How is Total Current Liabilities of MOREPEN LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹501 Cr | 24.53 | |
| Mar2024 | ₹402 Cr | 25.18 | |
| Mar2023 | ₹321 Cr | -29.64 | |
| Mar2022 | ₹456 Cr | 13.04 | |
| Mar2021 | ₹404 Cr | - | |
Compare Total Current Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹1,979.9 Cr | -2.4% | -22.2% | -26.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -2.4% |
-22.2% |
-26.4% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses